These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22192152)

  • 21. How to analyse epigenetic marks?
    Ammerpoht O; Siebert R
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():511-4. PubMed ID: 22423507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
    Tost J
    Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The growing role of gene methylation on endocrine function.
    García-Carpizo V; Ruiz-Llorente L; Fraga M; Aranda A
    J Mol Endocrinol; 2011 Oct; 47(2):R75-89. PubMed ID: 21803863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs, epigenetics and disease.
    Silahtaroglu A; Stenvang J
    Essays Biochem; 2010 Sep; 48(1):165-85. PubMed ID: 20822493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of early-life environment and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies.
    Sun C; Burgner DP; Ponsonby AL; Saffery R; Huang RC; Vuillermin PJ; Cheung M; Craig JM
    Pediatr Res; 2013 Apr; 73(4 Pt 2):523-30. PubMed ID: 23314296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of nutrition during early life on the epigenetic regulation of transcription and implications for human diseases.
    Lillycrop KA; Burdge GC
    J Nutrigenet Nutrigenomics; 2011; 4(5):248-60. PubMed ID: 22353662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
    Ahmed FE
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Waddington's epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research.
    Choudhuri S
    Toxicol Mech Methods; 2011 May; 21(4):252-74. PubMed ID: 21495865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility.
    Portha B; Fournier A; Kioon MD; Mezger V; Movassat J
    Biochimie; 2014 Feb; 97():1-15. PubMed ID: 24139903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic-related therapeutic challenges in cardiovascular disease.
    Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
    Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics and cardiovascular disease.
    Webster AL; Yan MS; Marsden PA
    Can J Cardiol; 2013 Jan; 29(1):46-57. PubMed ID: 23261320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The integration of epigenetics and genetics in nutrition research for CVD risk factors.
    Ma Y; Ordovas JM
    Proc Nutr Soc; 2017 Aug; 76(3):333-346. PubMed ID: 27919301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of DNA Methylation in Cardiovascular Risk and Disease: Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies.
    Zhong J; Agha G; Baccarelli AA
    Circ Res; 2016 Jan; 118(1):119-131. PubMed ID: 26837743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of epigenetic modifications in cardiovascular disease: A systematic review.
    Muka T; Koromani F; Portilla E; O'Connor A; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Int J Cardiol; 2016 Jun; 212():174-83. PubMed ID: 27038728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetics and methylation in the rheumatic diseases.
    Zufferey F; Williams FM; Spector TD
    Semin Arthritis Rheum; 2014 Apr; 43(5):692-700. PubMed ID: 24231066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation and incident cardiovascular disease.
    Westerman KE; Ordovás JM
    Curr Opin Clin Nutr Metab Care; 2020 Jul; 23(4):236-240. PubMed ID: 32487875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases.
    Gluckman PD; Hanson MA; Buklijas T; Low FM; Beedle AS
    Nat Rev Endocrinol; 2009 Jul; 5(7):401-8. PubMed ID: 19488075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on epigenetics and childhood respiratory diseases.
    Gruzieva O; Merid SK; Melén E
    Paediatr Respir Rev; 2014 Dec; 15(4):348-54. PubMed ID: 25151612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of epigenetics on cardiovascular disease.
    Prasher D; Greenway SC; Singh RB
    Biochem Cell Biol; 2020 Feb; 98(1):12-22. PubMed ID: 31112654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics and cardiovascular disease.
    Ordovás JM; Smith CE
    Nat Rev Cardiol; 2010 Sep; 7(9):510-9. PubMed ID: 20603647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.